ESR1 and breast carcinoma: Furthermore, several lines of evidence demonstrate that miR-20b downregulates ERα; (estrogen receptor alpha) [21] and modulates VEGF expression by targeting HIF-1α and STAT3[22] in MCF7 breast cancer cells.